CİRO ROMANO, VALENTİNA SİROTTİ, VİNCENZA FARİNARO, VİTTORİO LUİSO, ELEONORA SOLARO, CHİARA DE SİO, ANNA SALEMME, ANDREA DEL MASTRO, RİCCARDO GİUNTA
European Journal of Rheumatology - 2017;4(3):231-233
Atrial fibrillation following high-dose i.v. steroids for treatment of severe immune-mediated diseases has been rarely reported in the literature. Here we report a further case of atrial fibrillation following high-dose i.v. methylprednisolone (HDIVMP) therapy of severe thrombocytopenia in a female patient with a flare-up of systemic lupus erythematosus (SLE). The available literature on this topic is reviewed as well.
